Cell type | Treatment | %CD44 high | % Annexin positive cells in CD44 low | % Annexin positive cells in CD44 high | % cells in G2 in CD44 low | % cells in G2 in CD44 high |
---|---|---|---|---|---|---|
HNSCC derived cells (n = 11) | Â | Â | Â | Â | Â | Â |
 | Ctrl 24 h | 3.9 ± 0.4 | 15.1 ± 11.5 | 8.9 ± 8.9 | 12.9 ± 1.2 | 23.0 ± 2.2## |
 | 250 μM CP 24 h | 6.8 ± 1.0* | 38.5 ± 19.5 | 22.1 ± 16.7 | 15.0 ± 2.1 | 41.1 ± 9.7# |
 | 20 ng/ml NCZ 24 h | 6.0 ± 0.8 | 19.9 ± 10.3 | 3.5 ± 2.8 | 11.6 ± 1.9 | 31.4 ± 6.0# |
 | Ctrl 48 h | 4.3 ± 0.7 | 14.9 ± 7.6 | 2.5 ± 1.6 | 14.1 ± 3.1 | 23.5 ± 5.3 |
 | 20 ng/ml NCZ48 h | 11.0 ± 3.9** | 36.3 ± 16.3 | 11.0 ± 4.8 | 17.1 ± 2.9 | 76.9 ± 23.2** |
NOK (n = 5) | Â | Â | Â | Â | Â | Â |
 | Ctrl 24 h | 4.8 ± 1.7 | 5.2 ± 0.9 | 0.7 ± 0.4## | 10.4 ± 1.9 | 20.9 ± 2.6# |
 | 10mJ UV 24 h | 7.5 ± 2.8 | 7.5 ± 2.8 | 1.3 ± 0.5# | 28.9 ± 2.1* | 44.9 ± 4.7## |
 | Ctrl 48 h | 3.3 ± 0.6 | 15 ± 4.5 | 2.1 ± 0.3# | 11.6 ± 1.8 | 16.0 ± 2.3 |
 | 250 μM CP 48 h | 4.6 ± 0.9 | 28.8 ± 4.0 | 3.6 ± 0.5* ## | 15.8 ± 4.0 | 28.6 ± 2.3 |